By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Genaissance Pharmaceuticals, Inc. 

Five Science Park

New Haven  Connecticut  06511  U.S.A.
Phone: 203-773-1450 Fax: 203-562-9377


SEARCH JOBS


Industry
Biotechnology

Segment
Genomics





Company News
Clinical Data Completes Acquisition Of Genaissance Pharmaceuticals, Inc. (GNSC)10/19/2005 5:13:19 PM
Genaissance Pharmaceuticals, Inc. (GNSC) And ParAllele Bioscience, Inc. Sign License And Co-Marketing Agreement10/19/2005 5:13:13 PM
Genaissance Pharmaceuticals, Inc. (GNSC) To Present At CIBC World Markets Annual Biotechnology And Specialty Pharmaceuticals Conference10/19/2005 5:13:10 PM
Genaissance Pharmaceuticals, Inc. (GNSC) Comments On FDA Guidance On Pharmacogenomics10/19/2005 5:13:06 PM
Genaissance Pharmaceuticals, Inc. (GNSC) Allowed Patent For Method Of Testing Individuals For Genetic Predisposition To Reduced Metabolism Of Drugs10/19/2005 5:13:00 PM
Genaissance Pharmaceuticals, Inc. (GNSC) And Monsanto Company (MON) Team Up With The USDA To Map Soybean Genome10/19/2005 5:12:58 PM
Genaissance Pharmaceuticals, Inc.'s (GNSC) New DNA Test; FAMILION(TM) - Becoming Key Tool For Detecting Long QT Syndrome, A Potentially Fatal Cardiac Disorder10/19/2005 5:12:44 PM
Genaissance Pharmaceuticals, Inc. (GNSC) Reports 2004 Results10/19/2005 5:12:41 PM
Genaissance Pharmaceuticals, Inc. (GNSC) Invites You To Participate In Its Fourth Quarter 2004 Conference Call10/19/2005 5:12:37 PM
Genaissance Pharmaceuticals, Inc. (GNSC) Obtains License To Vanderbilt Patent Linking Genetics To Key Drug Safety Issue10/19/2005 5:12:33 PM
1234567
//-->